Evidence map›Paper›PMID 40102979›Full record

ArticleActa neuropathologica communications2025

Spatiotemporal perturbations of the plasminogen activation system in a rat model of acute organophosphate intoxication.

Thomas J Blackmon, Jeremy A MacMahon, Pedro N Bernardino, Ryan E Hogans, Mei-Yun Cheng, Joan Vu, Ruth Diana Lee, Naomi H Saito, Ana Cristina Grodzki, Donald A Bruun and 6 more

Abstract read
In one paragraph

Article in Acta neuropathologica communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Thomas J Blackmon *Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA, 95616, USA.
Jeremy A MacMahon *Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA, 95616, USA.
Pedro N BernardinoDepartment of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA, 95616, USA.
Ryan E HogansDepartment of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA, 95616, USA.
Mei-Yun ChengDepartment of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA, 95616, USA.
Joan VuDepartment of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA, 95616, USA.
Ruth Diana LeeDepartment of Pharmacology, School of Medicine, University of California, Davis, CA, 95616, USA.
Naomi H SaitoDepartment of Public Health Sciences, School of Medicine, University of California, Davis, CA, 95616, USA.
Ana Cristina GrodzkiDepartment of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA, 95616, USA.
Donald A BruunDepartment of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA, 95616, USA.
Heike WulffDepartment of Pharmacology, School of Medicine, University of California, Davis, CA, 95616, USA.
Kevin D WoolardDepartment of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California, Davis, CA, 95616, USA.
Amy Brooks-KayalDepartment of Neurology, School of Medicine, University of California, Davis, Sacramento, CA, 95817, USA.
Danielle J HarveyDepartment of Public Health Sciences, School of Medicine, University of California, Davis, CA, 95616, USA.
Fredric A GorinDepartment of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA, 95616, USA.
Pamela J LeinDepartment of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA, 95616, USA. pjlein@ucdavis.edu.

Funding

Training and Education CoreU54NS079202 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HAMMOCK, BRUCE D · 2012 to 2021
$35.7M
UC Davis CounterACT Center of Excellence: Developing Therapeutic Strategies for Mitigating the Chronic Neurological Consequences of Acute Organophosphate IntoxicationU54NS127758 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Pamela J Lein · 2022 to 2026
$17.2M
Research Project: Pathologic Significance of Maternal AutoantibodiesP50HD103526 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEONARD J. ABBEDUTO, Melissa Dawn Bauman · 2020 to 2026
$9.7M
Predoctoral Training in Pharmacological SciencesT32GM099608 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HELL, JOHANNES W · 2012 to 2021
$2.2M
Training Program in PharmacologyT32GM144303 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Donald M Bers, JOHANNES W HELL · 2022 to 2026
$2.1M
NICHD NIH HHS P50 HD103526NIGMS NIH HHS T32 GM099608NIGMS NIH HHS T32 GM144303NINDS NIH HHS U54 NS079202NINDS NIH HHS U54 NS127758School of Veterinary Medicine, University of California, Davis 2022-2023 Lodric Maddox Graduate Fellowship
6 · The paper itself

Abstract

Neuroinflammation is widely posited to be a key pathogenic mechanism linking acute organophosphate (OP)-induced status epilepticus (SE) to persistent brain injury and abnormal electrical activity that contribute to epilepsy and cognitive impairment. The plasminogen activation system (PAS) promotes neuroinflammation in diverse neurological diseases but whether it is activated following acute OP intoxication has yet to be evaluated. To address this data gap, we characterized the spatiotemporal expression patterns of multiple components of the PAS in a rat model of acute intoxication with the OP, diisopropylfluorophosphate (DFP). Adult male Sprague Dawley rats administered DFP (4 mg/kg, sc), atropine sulfate (2 mg/kg, im) and 2-pralidoxime (25 mg/kg, im) went into SE that persisted for hours. One day after acute DFP-induced SE, plasmin activity and protein concentrations of plasminogen activator inhibitor-1 (PAI-1) in the plasma were increased, though not significantly. In contrast, acute DFP intoxication significantly increased brain levels of PAI-1, tissue-type plasminogen activator (tPA), urokinase plasminogen activator (uPA), and transcripts of TGF-β in a time- and region-dependent manner. In the cortex and hippocampus, quantification of PAI-1, tPA, and uPA by ELISA indicated significantly increased levels at 1 day post-exposure (DPE). PAI-1 and uPA returned to control values by 7 DPE while tPA protein remained elevated at 28 DPE. Immunohistochemistry detected elevated PAI-1 expression in the DFP brain up to 28 DPE. Co-localization of PAI-1 with biomarkers of neurons, microglia, and astrocytes demonstrated that PAI-1 localized predominantly to a subpopulation of astrocytes. Cytologically, PAI-1 localized to astrocytic end feet, but not adjacent neurovascular endothelium. Electron microscopy revealed neuronal metabolic stress and neurodegeneration with disruption of adjacent neurovascular units in the hippocampus post-DFP exposure. These data indicate that acute DFP intoxication altered PAS expression in the brain, with aberrant PAI-1 expression in a subset of reactive astrocyte populations.

Indexed as

BrainOrganophosphate PoisoningPlasminogenPlasminogen ActivatorsStatus EpilepticusAnimalsDisease Models, AnimalIsoflurophateMalePlasminogen Activator Inhibitor 1Pralidoxime CompoundsRatsRats, Sprague-DawleyTissue Plasminogen ActivatorIsoflurophatePlasminogenPlasminogen Activator Inhibitor 1Plasminogen ActivatorspralidoximePralidoxime CompoundsTissue Plasminogen ActivatorBlood-brain barrierDiisopropylfluorophosphateEpilepsyNeuroinflammationPlasminogen activator inhibitor-1 (PAI-1)

Identifiers

PMID40102979
PMCPMC11917081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.